KAUFMAN, MICHAEL D,CALDWELL, TIMOTHY MALCOLM,FLYNN, DANIEL L,PATT, WILLIAM C,SAMARAKOON, THIWANKA,VOGETI, LAKSHMINARAYANA,YATES, KAREN M
申请号：
PH12015502336
公开号：
PH12015502336A1
申请日:
2015.10.08
申请国别(地区):
PH
年份:
2016
代理人:
摘要：
Described are compounds of Formula I, which find utility in the treatment of cancer, autoimmune diseases and metabolic bone disorders through inhibition of c-FMS (CSF-IR), c-KIT, and/or PDGFR kinases. These compounds also find utility in the treatment of other mammalian diseases mediated by c- FMS, c-KIT, or PDGFR kinases.
